Royal Bank of Canada’s Codiak BioSciences, Inc. Common Stock CDAK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-148
| Closed | – | – | 7453 |
|
2022
Q3 | $0 | Buy |
+148
| New | – | ﹤0.01% | 7534 |
|
2022
Q2 | – | Sell |
-978
| Closed | -$6K | – | 7414 |
|
2022
Q1 | $6K | Sell |
978
-2,605
| -73% | -$16K | ﹤0.01% | 6737 |
|
2021
Q4 | $40K | Buy |
3,583
+2,053
| +134% | +$22.9K | ﹤0.01% | 5972 |
|
2021
Q3 | $25K | Buy |
1,530
+455
| +42% | +$7.44K | ﹤0.01% | 6069 |
|
2021
Q2 | $20K | Buy |
1,075
+347
| +48% | +$6.46K | ﹤0.01% | 6073 |
|
2021
Q1 | $11K | Sell |
728
-642
| -47% | -$9.7K | ﹤0.01% | 6287 |
|
2020
Q4 | $44K | Buy |
+1,370
| New | +$44K | ﹤0.01% | 5173 |
|